It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Kinetoplastid parasites, included Trypanosoma cruzi, the causal agent of Chagas disease, present a unique genome organization and gene expression. Although they control gene expression mainly post-transcriptionally, chromatin accessibility plays a fundamental role in transcription initiation control. We have previously shown that High Mobility Group B protein from Trypanosoma cruzi (TcHMGB) can bind DNA in vitro. Here, we show that TcHMGB also acts as an architectural protein in vivo, since the overexpression of this protein induces changes in the nuclear structure, mainly the reduction of the nucleolus and a decrease in the heterochromatin:euchromatin ratio. Epimastigote replication rate was markedly reduced presumably due to a delayed cell cycle progression with accumulation of parasites in G2/M phase and impaired cytokinesis. Some functions involved in pathogenesis were also altered in TcHMGB-overexpressing parasites, like the decreased efficiency of trypomastigotes to infect cells in vitro, the reduction of intracellular amastigotes replication and the number of released trypomastigotes. Taken together, our results suggest that the TcHMGB protein is a pleiotropic player that controls cell phenotype and it is involved in key cellular processes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Instituto de Biología Molecular y Celular de Rosario (IBR), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Rosario, Argentina (GRID:grid.423606.5) (ISNI:0000 0001 1945 2152)
2 Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Laboratorio de Ultraestrutura Celular Hertha Meyer, Rio de Janeiro, Brazil (GRID:grid.8536.8) (ISNI:0000 0001 2294 473X)
3 Laboratório Especial de Ciclo Celular, Instituto Butantan, São Paulo, Brazil (GRID:grid.418514.d) (ISNI:0000 0001 1702 8585); Instituto Butantan, Center of Toxins, Immune Response and Cell Signaling – CeTICS, São Paulo, Brazil (GRID:grid.418514.d) (ISNI:0000 0001 1702 8585)
4 Universidad Nacional de Rosario (UNR), Facultad de Ciencias Bioquímicas y Farmacéuticas, Cátedra de Parasitología, Rosario, Argentina (GRID:grid.10814.3c) (ISNI:0000 0001 2097 3211)
5 Instituto de Biología Molecular y Celular de Rosario (IBR), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Rosario, Argentina (GRID:grid.423606.5) (ISNI:0000 0001 1945 2152); Universidad Nacional de Rosario (UNR), Facultad de Ciencias Bioquímicas y Farmacéuticas, Cátedra de Parasitología, Rosario, Argentina (GRID:grid.10814.3c) (ISNI:0000 0001 2097 3211)